We are monitoring the impact of COVID-19 on Europe Immunoassay Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1491
Share on
Share on

Europe Immunoassay Market Research Report – Segmented By Technology, Application, End Users, Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends and Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1491
Pages: 132

Europe Immunoassay Market Size (2021 to 2026)

The size of the European Immunoassay Market was valued at USD 5.66 Billion in 2021. It is estimated to reach USD 9.03 Billion by the end of 2026, growing at a CAGR of 9.82% between 2021 to 2026. Europe expected to show reasonable growth due to growing immune assays' applications in diagnosing drug testing for various diseases.

Immunoassays are crucial in the diagnosis and treatment planning of diseases. As a result, the market has grown due to an increase in the prevalence of chronic diseases such as cancer, cardiovascular disease, and diabetes mellitus, as well as the development of a technologically improved automated immunoassay for their diagnosis. Also, the immunoassay market is growing due to the rising demand for point-of-care testing equipment and an increasing acceptance rate of these devices. In addition, infections and chronic diseases are increasing in frequency, supporting the European immunoassays market's growth.

The immunoassay market is expected to rise because of increased public awareness of point-of-care devices and government incentives to create testing equipment.  While considering the emergence of the new coronavirus (COVID-19), there has been a critical demand for diagnostic solutions, particularly immunoassay, which is regarded as fundamental in pandemic management.

The European immunoassays market is expected to benefit from improved regulatory processes for innovative devices to develop treatments. Furthermore, during the projected period, the growing demand for safer medications and specialty therapies is expected to provide profitable possibilities for market players in the area.

The EU regulatory authorities have drafted severe requirements for the licensing and commercialization of immunoassay consumables and instruments. Furthermore, technological challenges provided by immunoassay kits and reagents, such as cross-reactivity of antibodies, poor detection limits of accessible antibodies, false negatives, and others, stifle the immunoassay market's growth. Also, constantly changing reimbursement rules, very technical assay techniques, and the high cost of immunoassay kits are all factors limiting the growth of the European immunoassays market.

This research report on the European immunoassay market has been segmented & sub-segmented the market into the following categories:

By Technology:

  • Enzyme Immunoassays
  • Fluorescent Immunoassays
  • Chemiluminescence Immunoassays
  • Nephelometric Immunoassays
  • Radio Immunoassays
  • Counting Immunoassays
  • Turbidimetric Immunoassays

By Application:

  • Oncology
  • Cancer
  • Hematology
  • Cardiology
  • Thyroid
  • Infectious diseases
  • Allergies

By End User:

  • Hospitals
  • Clinics
  • Academic Research Institute
  • Pharmaceutical
  • Biotech vendors
  • Laboratories

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the European market is expected to account for the second-largest share of the global immunoassays market during the forecast period. The market growth is driven owing to the expanding applications of immune tests in diagnosing medication testing for various diseases. However, the introduction of technologically superior analyzers into the European market has boosted the market growth in the region tremendously. Furthermore, due to the exceptional COVID-19 outbreak, which has resulted in a shortage of diagnostics and infrastructure, the market is expected to rise significantly. This has generated a plethora of options for market players to close the gap between supply and demand. In addition, several research centers relevant to diagnostics, such as central laboratory testing and point of care tests, have resulted from considerable investment in the healthcare sector, both from the public and private sectors in this region.

The German immunoassays market dominated the European market with significant revenue in 2020 and is likely to hold this position throughout the forecast period. Because of Germany's supporting healthcare legislation, the market is expected to rise significantly. Furthermore, the presence of a sizable senior population in this country is a significant market driver.

On the other hand, the UK immunoassay market is estimated to register healthy CAGR during the forecast period due to the presence of modern healthcare infrastructure, high disposable income, increasing healthcare expenditure, and increased awareness about early disease diagnosis, the market in the United Kingdom is predicted to develop rapidly throughout the forecast period. Furthermore, the market for immunoassay analyzers is expanding owing to the high demand for diagnostics, which can be linked to the rising frequency of chronic diseases.

KEY MARKET PLAYERS:

A few of the notable companies operating in the European immunoassay market analyzed in this report are Roche Diagnostics, DiaSorin S.p. A, Beckman Coulter, Siemens Healthcare, Ortho Clinical Diagnostics, bioMerieux, Thermo Fisher Scientific and Abbott Laboratories, Akers Biosciences, Inc, Becton Dickinson and Company, Devon Medical Products, EDP Biotech Corporation, Hologic (Gen-Probe), Intrinsic LifeSciences.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Technology                

                                5.1.1 Introduction           

                                5.1.2 Enzyme Immunoassay       

                                5.1.3 Fluorescent Immunoassays             

                                5.1.4 Cheniluminescence Immunoassays              

                                5.1.5 Nephelometric Immunoassays       

                                5.1.6 Radio Immunoassays         

                                5.1.7 Counting Immunoassays  

                                5.1.8 Counting Immunoassays  

                                5.1.9 Others      

                                5.1.10 Y-o-Y Growth Analysis, By Technology      

                                5.1.11 Market Attractiveness Analysis, By Technology     

                                5.1.12 Market Share Analysis, By Technology      

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Oncology 

                                5.2.3 Cancer      

                                5.2.4 Hematology           

                                5.2.5 Cardiology               

                                5.2.6 Thyroid     

                                5.2.7 Infectious disease

                                5.2.8 Allergies   

                                5.2.9 Others      

                                5.2.10 Y-o-Y Growth Analysis, By Application       

                                5.2.11 Market Attractiveness Analysis, By Application     

                                5.2.12 Market Share Analysis, By Application      

                5.3 End users                    

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Academic research institutes          

                                5.3.5 Pharmaceutical and Biotech vendors           

                                5.3.6 Laboratories           

                                5.3.7 Others      

                                5.3.8 Y-o-Y Growth Analysis, By End users            

                                5.3.9 Market Attractiveness Analysis, By End users           

                                5.3.10 Market Share Analysis, By End users          

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Technology

                                                6.1.3.3 By Application

                                                6.1.3.4 By End users

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Technology

                                                6.1.4.3 By Application

                                                6.1.4.4 By End users

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Technology

                                                6.1.5.3 By Application

                                                6.1.5.4 By End users

                6.2 U.K                

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Roche Diagnostics                    

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 DiaSorin S.p.A                           

                8.3 Beckman Coulter                     

                8.4 Siemens Healthcare                

                8.5 Ortho Clinical Diagnostics                     

                8.6 bioMerieux                

                8.7 Thermo Fisher Scientific                        

                8.8 Abbott Laboratories               

                8.9 Akers Biosciences                    

                8.10 Becton Dickinson and Company                      

                8.11 Devon Medical Products                    

                8.12 EDP Biotech Corporation                    

                8.13 Hologic                       

                8.14 Intrinsic LifeSciences                           

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Immunoassays Market, By Technology, From 2021 to 2026 (USD Billion)
  2. Europe Enzyme Immunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  3. Europe Fluorescent Immunoassays Market, By Region, From 2021 to 2026 (USD Billion)
  4. Europe Cheniluminescence Immunoassays Market, By Region, From 2021 to 2026 (USD Billion)
  5. Europe Nephelometric Immunoassays Market, By Region, From 2021 to 2026 (USD Billion)
  6. Europe Radio Immunoassays Market, By Region, From 2021 to 2026 (USD Billion)
  7. Europe Counting Immunoassays Market, By Region, From 2021 to 2026 (USD Billion)
  8. Europe Turbidimetric Immunoassays Market, By Region, From 2021 to 2026 (USD Billion)
  9. Europe Immunoassays Market, By Application, From 2021 to 2026 (USD Billion)
  10. Europe Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  11. Europe Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  12. Europe Hematology Market, By Region, From 2021 to 2026 (USD Billion)
  13. Europe Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  14. Europe Thyroid Market, By Region, From 2021 to 2026 (USD Billion)
  15. Europe Infectious diseases Market, By Region, From 2021 to 2026 (USD Billion)
  16. Europe Allergies Market, By Region, From 2021 to 2026 (USD Billion)
  17. Europe Immunoassays Market, By End users, From 2021 to 2026 (USD Billion)
  18. Europe Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  19. Europe Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  20. Europe Academic research institutes Market, By Region, From 2021 to 2026 (USD Billion)
  21. Europe Pharmaceutical and biotech vendors Market, By Region, From 2021 to 2026 (USD Billion)
  22. Europe laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  23. U.K. Immunoassays Market, By Technology, From 2021 to 2026 (USD Billion)
  24. U.K. Immunoassays Market, By Application, From 2021 to 2026 (USD Billion)
  25. U.K. Immunoassays Market, By End users, From 2021 to 2026 (USD Billion)
  26. Germany Immunoassays Market, By Technology, From 2021 to 2026 (USD Billion)
  27. Germany Immunoassays Market, By Application, From 2021 to 2026 (USD Billion)
  28. Germany Immunoassays Market, By End users, From 2021 to 2026 (USD Billion)
  29. France Immunoassays Market, By Technology, From 2021 to 2026 (USD Billion)
  30. France Immunoassays Market, By Application, From 2021 to 2026 (USD Billion)
  31. France Immunoassays Market, By End users, From 2021 to 2026 (USD Billion)
  32. Italy Immunoassays Market, By Technology, From 2021 to 2026 (USD Billion)
  33. Italy Immunoassays Market, By Application, From 2021 to 2026 (USD Billion)
  34. Italy Immunoassays Market, By End users, From 2021 to 2026 (USD Billion)
  35. Spain Immunoassays Market, By Technology, From 2021 to 2026 (USD Billion)
  36. Spain Immunoassays Market, By Application, From 2021 to 2026 (USD Billion)
  37. Spain Immunoassays Market, By End users, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample